Quick Listen: Scrip's Five Must-Know Things

 
• By Ian Haydock

In this week's podcast version of Five Must-Know Things: etrasimod comes through for Pfizer; PTC confident on gene therapy; could CAR-Ts roll into the community setting; the attractions of Boston for Korean bioventures; and Ukraine war may claim Sputnik casualties.

Scrip Five Must Know Things
audio roundup of selected biopharma insights from Scrip's global team

More from Business

More from Scrip